Royalty Pharma (RPRX) EPS (Basic) (2020 - 2026)
Royalty Pharma (RPRX) reported EPS (Basic) of $1.07 for Q1 2026, up 7.46% on a YoY basis from $1.0 in Q1 2025, and up 29.46% sequentially from $0.83 in Q4 2025.
Royalty Pharma (RPRX) EPS (Basic) (2020 - 2026) Analysis & Trends
Royalty Pharma (RPRX) has 7 years of EPS (Basic) data on file, last reported at $1.07 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) rose 7.46% year-over-year to $1.07; the trailing twelve-month figure through Mar 2026 stood at $3.11 (down 23.43% YoY), and the FY2025 full-year result was $3.08, up 3.76% from the prior year.
- EPS (Basic) grew to $1.07 in Q1 2026, from $0.83 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $1.8 in Q3 2024 to a low of -$1.39 in Q4 2022.
- A 5-year average of $0.67 and a median of $0.78 in 2023 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) tumbled 1176.48% in 2022 and surged 10573.77% in 2025, its largest moves.
- Tracing RPRX's EPS (Basic) over 5 years: stood at -$1.39 in 2022, then soared by 215.1% to $1.6 in 2023, then slumped by 53.47% to $0.75 in 2024, then rose by 11.0% to $0.83 in 2025, then gained by 29.46% to $1.07 in 2026.
- Business Quant data shows RPRX's EPS (Basic) at $1.07 in Q1 2026, $0.83 in Q4 2025, and $1.03 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Royalty Pharma | 25.70 Bn | 25.09 Bn | - | 1.07 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.07 |
| Dec 31, 2025 | 0.83 |
| Sep 30, 2025 | 1.03 |
| Jun 30, 2025 | 0.21 |
| Mar 31, 2025 | 1.00 |
| Dec 31, 2024 | 0.75 |
| Sep 30, 2024 | 1.80 |
| Jun 30, 2024 | 0.43 |
| Mar 31, 2024 | -0.01 |
| Dec 31, 2023 | 1.60 |
| Sep 30, 2023 | 0.27 |
| Jun 30, 2023 | 0.78 |
| Mar 31, 2023 | 1.14 |
| Dec 31, 2022 | -1.39 |
| Sep 30, 2022 | 0.50 |
| Jun 30, 2022 | 1.13 |
| Mar 31, 2022 | 0.30 |
| Dec 31, 2021 | 0.13 |
| Sep 30, 2021 | 0.52 |
| Jun 30, 2021 | 1.97 |